3 results
Approved WMORecruitment stopped
The primary purpose of the study is to investigate whether the new 20 mg capsule of Orfadin® (nitisinone) has a similar bioavailability in the body (gives the same concentration in the blood) as two of the marketed capsules of 10 mg. The secundary…
Not applicableRecruitment stopped
Objective: The primary objective of the study is determining the contributing factors in bracing for AIS. The contributing factors are determined as factors of influence in the corrective possibilities and therefore end term…
Positive opinionRecruiting
Bone-anchored maxillary protraction therapy improves facial profile in cleft children.